Abstract
The DIAS system utilizes a control to range-based algorithm for glucose control in type 1 diabetes. The system includes a Dexcom G4 sensor, a Roche AccuCheck pump and an Android-based DIAS controller. The objective of this study was to test the safety and efficacy of DIAS in subjects with type 1 diabetes, aged 10-35 y, over 5 days at diabetes camp. There were 33 subjects randomized to either closed-loop with DIAS (intervention) or sensor-augmented pump (control) for 5 days at diabetes camp. Both groups utilized premeal boluses.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
